Navigation Links
Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen

omprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncology 2006; 7 (8): 633-643 Saphner T, Tormey DC and Gray R. Annual Hazard Rates of Recurrence for Breast cancer After Primary Therapy. J Clin Onc 1996; 14: 2738-2746 Coombes RC. First Mature Analysis of the Intergroup Exemestane study. Abstract Number LBA527, 2006 ASCO Annual Meeting


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
3. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
4. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
5. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
6. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
7. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
8. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
9. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
10. Once Daily, Extended-Release Ropinirole Improves Parkinsons Symptoms in Patients not Optimally Controlled With Levodopa
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
Post Your Comments:
(Date:5/12/2008)...st their function like a radio dial, not an on/off...mmune disease may develop,late in life, MEMPHIS...ude Children,s,Research Hospital study shows that ...ot use simple on/off switches to govern the cellul...function. Rather, they,possess sophisticated molec...
(Date:5/12/2008)...ay 12 /- Arbios Systems, In... the Company has received,approval from the U.S. F...ational Device Exemption ("IDE") to begin the pivo...poreal (outside the body) liver assist,device for ...ng from,chronic liver disease., "We are pleased t...
(Date:5/12/2008)...hort 3 Demonstrated Improvement in T-Cell Response...tial of HspE7, SAN DIEGO, May 12 /PRNewswire-Firs...SX: NVN) today announced positive immunological da...inical trial of its lead product,candidate, HspE7,...ia, or,CIN, a precursor to cervical cancer. HPV 16...
(Date:5/9/2008)...9 /PRNewswire-USNewswire/ -- Many strong acting pa... can include nausea and,vomiting with short-term u...h symptoms can lead patients to discontinue treatm...ement for physicians. The novel investigational,me...esic, provided pain,relief for patients with fewer...
Breaking Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results 1609 1Palatin Technologies Inc Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 708 1Palatin Technologies Inc Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 708 2Palatin Technologies Inc Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 708 3US government delays nanotechnology safety measures 1048 1US government delays nanotechnology safety measures 1048 2Modigene to Present at Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1606 1Modigene to Present at Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1606 2
...s Unique Mechanism of Action and Broad Potential f...EDA, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avi...ny innovating therapeutics,for the treatment of ne... Opinion on Investigational Drugs has published an...1 (ibudilast), a potential,first-in-class, non-opi...
...SS WIRE)--Jun 27, 2007 - The University of,Pittsbu... study and,press release, "Scientists Culture Bloo...15, 2007, Science Daily: "Researchers at,the Unive...sfully,isolated and cultured human hematopoietic s...that they have found another important,source of c...
Other Medicine Technology:Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells 2Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells 3
(Date:5/13/2008)... Improve Your Child,s Comfort and Performance duri...wswire/ -- The Good Feet Stores, a,California base...ports and,natural sponge rubber cushions, announce...rts designed specifically for children ages 6 and ... the "SportFlex," are now,currently available at p...
(Date:5/13/2008)...ATLANTA, May 13 /PRNewswire/ -- Annually, allergie...s, causing untold suffering, sneezing and,wheezing...ication., However, putting the right air treatmen... home can create a healthier living environment an...home health specialist and,president of Sylvane.co...
(Date:5/12/2008)...YOKNEAM, Israel, May 13 /PRNewswire/ -- Lumenis In... laser, light-based and radiofrequency,devices for... announced,today the launch of a Holmium Laser Enu... that will provide training opportunities for urol...ng HoLEP. The abundance of,clinical evidence sugge...
(Date:5/12/2008)...DIANAPOLIS A study published in the May/June issue... trial providing a scientifically valid look at wh...t programs that serve low-income individuals. The ... leaders struggling to meet the needs of individua...some disease management efforts, even among relati...
Breaking Medicine News(10 mins):Health News:Good Feet Announces New Arch Support Product Line for Children Ages 6 and Older 2Health News:Simple Steps to a Healthier, Allergy-Free Home 2Health News:Simple Steps to a Healthier, Allergy-Free Home 3Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 3Health News:Chronic disease management: Does it improve health and save money? 2
...nuing Medical Education Programme 'CME- Orth 2005'...of Kasturba Hospital, Manipal from November 4 to 6...al case discussions and demonstration of orthosis,...es. The programme was inaugurated by Dr. R S P ...
...is no doubt the wonder food. With a plethora of me...gests that garlic may ward off evil spirits, such ...c, //or a flavour component of pungent herb, may h...oduced by meat cooked at high temperatures. Cooki...
...tudy says that a key enzyme present in skin cancer...triggering the spread of the cancer to other parts...inase (FAK) is actually a critical component of th...in many cellular activities. But this enzyme's les...
...d flu vaccine is to be developed from this year’s ...from wild birds which has killed wild and migrator...e of World Health Organization (WHO). //WHO has gi...WCS) Veterinarian to prepare the vaccine which wou...
Other Medicine News:
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity.
It is lightweight and portable headlight option for office exam room. It offers complete comfort and portability.
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost.
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband.
Medicine Products: